Literature DB >> 9792626

Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter.

C Z Song1, T E Siok, T D Gelehrter.   

Abstract

The transforming growth factor-beta (TGF-beta) family of cytokines mediates multiple biological effects by regulating the expression of target genes. The Smad family proteins function as intracellular signal transducers downstream of the receptors to transmit the TGF-beta signal from cell membrane to nucleus. The mechanisms by which Smads mediate transcriptional activation of target genes is largely unknown. Here we report the identification of a novel TGF-beta-responsive element in the human type 1 plasminogen activator inhibitor promoter that is required for mediating strong transcriptional activation of this gene by TGF-beta. Smad3 and Smad4 are incorporated into a TGF-beta-inducible complex formed on this element following TGF-beta stimulation of human hepatoma cells. Both Smad3 and Smad4 bind directly to this TGF-beta-responsive element through their conserved MH1 domains. These results indicate that Smad3 and Smad4 mediate TGF-beta signaling by directly interacting with a specific response element in a physiological target gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792626     DOI: 10.1074/jbc.273.45.29287

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Transcriptional regulation of BMP4 synexpression in transgenic Xenopus.

Authors:  Emil Karaulanov; Walter Knöchel; Christof Niehrs
Journal:  EMBO J       Date:  2004-02-12       Impact factor: 11.598

2.  Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway.

Authors:  B J Warner; S W Blain; J Seoane; J Massagué
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter.

Authors:  N G Denissova; C Pouponnot; J Long; D He; F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  Thrombospondin 1 as a novel biological marker of obesity and metabolic syndrome.

Authors:  Yoshiyuki Matsuo; Masashi Tanaka; Hajime Yamakage; Yousuke Sasaki; Kazuya Muranaka; Hiroaki Hata; Iwao Ikai; Akira Shimatsu; Mayumi Inoue; Tae-Hwa Chun; Noriko Satoh-Asahara
Journal:  Metabolism       Date:  2015-07-26       Impact factor: 8.694

5.  Insulin acts through FOXO3a to activate transcription of plasminogen activator inhibitor type 1.

Authors:  Ushma R Jag; Jiri Zavadil; Frederick M Stanley
Journal:  Mol Endocrinol       Date:  2009-07-16

Review 6.  Adipocytokines and the metabolic complications of obesity.

Authors:  Neda Rasouli; Philip A Kern
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

7.  Inhibition of plasminogen activator inhibitor-1 expression in vascular smooth muscle cells by protoporphyrins through a heme oxygenase-independent mechanism.

Authors:  Xilin Long; Andrew I Schafer
Journal:  Mol Cell Biochem       Date:  2008-03-16       Impact factor: 3.396

8.  Increased cell migration and plasticity in Nrf2-deficient cancer cell lines.

Authors:  G Rachakonda; K R Sekhar; D Jowhar; P C Samson; J P Wikswo; R D Beauchamp; P K Datta; M L Freeman
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

9.  Requirement of a dynein light chain in TGFbeta/Smad3 signaling.

Authors:  Qunyan Jin; Guofeng Gao; Kathleen M Mulder
Journal:  J Cell Physiol       Date:  2009-12       Impact factor: 6.384

10.  An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules.

Authors:  Huaxia Qin; Michael W Y Chan; Sandya Liyanarachchi; Curtis Balch; Dustin Potter; Irene J Souriraj; Alfred S L Cheng; Francisco J Agosto-Perez; Elena V Nikonova; Pearlly S Yan; Huey-Jen Lin; Kenneth P Nephew; Joel H Saltz; Louise C Showe; Tim H M Huang; Ramana V Davuluri
Journal:  BMC Syst Biol       Date:  2009-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.